FDA Inspection 1322450 — Marcelo Eduardo Zanella Capra, M.D.
The FDA completed an inspection of Marcelo Eduardo Zanella Capra, M.D. on May 19, 2026 in Porto Alegre. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 19, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Porto Alegre (Brazil)
Additional Details
Clinical Investigator (CI)